Загрузка...
Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis
Currently there is no treatment available to improve a stable deficit in multiple sclerosis. It was shown in animal models that intravenous immunoglobulins (IVIg) can enhance central nervous remyelination, and the first open trials were promising. We therefore conducted a double blind, placebo contr...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Group
2000
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1760582/ https://ncbi.nlm.nih.gov/pubmed/10601410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.68.1.89 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|